XML 154 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income/(Loss)
Accumulated Other Comprehensive Income/(Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Total MiX Telematics Limited Stockholders' Equity
Total MiX Telematics Limited Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Total MiX Telematics Limited Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-Controlling Interest
Non-Controlling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Cumulative Currency Translation Adjustments
Beginning balance (in shares) at Mar. 31, 2017       603,435,000                                
Beginning balance at Mar. 31, 2017 $ 104,249     $ 73,158   $ (9,227)   $ 7,835   $ (7,990)   $ 40,589     $ 104,365     $ (116)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Total comprehensive income/(loss) 23,706             9,754       13,947     23,701     5    
Net income for the year 13,952                     13,947     13,947     5    
Other comprehensive income (loss) 9,754             9,754             9,754          
Total transactions with owners (in shares)       985,000                                
Total transactions with owners (4,017)     $ (611)           577   (4,099)     (4,133)     116    
Issuance of common stock in relation to stock options and SARs exercised (in shares)       6,001,000                                
Issuance of common stock in relation to stock options and SARs exercised 825     $ 825                     825          
Stock-based compensation 693                 693         693          
Dividends declared on ordinary shares (4,099)                     (4,099)     (4,099)          
Transactions with non-controlling interest                   (116)         (116)     116    
Ordinary shares repurchased and cancelled (in shares)       5,016,000                                
Ordinary shares repurchased and cancelled (1,436)     $ (1,436)                     (1,436)          
Ending balance (in shares) at Mar. 31, 2018       604,420,000 604,420,000                              
Ending balance at Mar. 31, 2018 123,938 $ 2,417 $ 126,355 $ 72,547 $ 72,547 (9,227) $ (9,227) 17,589 $ 17,589 (7,413) $ (7,413) 50,437 $ 2,417 $ 52,854 123,933 $ 2,417 $ 126,350 5 $ 5  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Total comprehensive income/(loss) (664)             (15,474)       14,810     (664)     0    
Net income for the year 14,810                     14,810     14,810     0    
Other comprehensive income (loss) (15,474)             (15,474)             (15,474)         $ (15,474)
Total transactions with owners (in shares)       (2,473,000)                                
Total transactions with owners (8,750)     $ (4,347)           511   (4,914)     (8,750)          
Issuance of common stock in relation to stock options and SARs exercised (in shares)       6,685,000                                
Issuance of common stock in relation to stock options and SARs exercised 1,002     $ 1,002                     1,002          
Stock-based compensation 511                 511         511          
Dividends declared on ordinary shares (4,914)                     (4,914)     (4,914)          
Ordinary shares repurchased and cancelled (in shares)       9,158,000                                
Ordinary shares repurchased and cancelled $ (5,349)     $ (5,349)                     (5,349)          
Ending balance (in shares) at Mar. 31, 2019 601,900,000     601,948,000 601,948,000                              
Ending balance at Mar. 31, 2019 $ 116,941 $ (262) $ 116,679 $ 68,200 $ 68,200 (9,227) $ (9,227)   $ 2,093 (6,902) $ (6,902) 62,750 $ (240) $ 62,510 116,936 $ (262) $ 116,674 5 $ 5 2,115
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Total comprehensive income/(loss) (2,176)             (13,163)       10,987     (2,176)     0    
Net income for the year 10,987                     10,987     10,987     0    
Other comprehensive income (loss) (13,163)             (13,163)             (13,163)         $ (13,163)
Total transactions with owners (in shares)       (1,013,000)                                
Total transactions with owners (15,478)     $ (1,678)   (8,088)       303   (6,015)     (15,478)          
Issuance of common stock in relation to stock options and SARs exercised (in shares)       2,026,000                                
Stock-based compensation 303                 303         303          
Dividends declared on ordinary shares (6,015)                     (6,015)     (6,015)          
Ordinary shares repurchased and cancelled (in shares)       3,039,000                                
Ordinary shares repurchased and cancelled (1,678)     $ (1,678)                     (1,678)          
Purchases of treasury stock $ (8,088)         (8,088)                 (8,088)          
Ending balance (in shares) at Mar. 31, 2020 600,900,000     600,934,000                                
Ending balance at Mar. 31, 2020 $ 99,025     $ 66,522   $ (17,315)   $ (11,070)   $ (6,599)   $ 67,482     $ 99,020     $ 5